Triazolopyrazine derivatives

Details Triazolopyrazine derivatives Triazolopyrazine derivatives

2007-05-08

2010-06-08

Wilson, James O (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

Reexamination Certificate

active

07732604

ABSTRACT:
The invention relates to compounds of the formula Ior a pharmaceutically acceptable salt thereof, wherein R1, R2, R3and R4are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.

REFERENCES:
patent: 6660744 (2003-12-01), Hirst et al.
patent: WO2005/004607 (2005-01-01), None
patent: WO 2005 004607 (2005-01-01), None
patent: WO 2005 028480 (2005-03-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Ma, P., et al., “c-METMutational Analysis in Small Cell Lung Cancer: Novel Juxtamembrane Domain Mutations Regulating Cytoskeletal Functions,”Cancer Research, 2003, 6272-6281, vol. 63.
Ma, P., et al., “c-MET: Structure, Functions and Potential for Therapeutic Inhibition,”Cancer and Metastasis Reviews, 2003, 309-325, vol. 22.
Maulik, G., et al., “Role of the Hepatocyte Growth Factor Receptor, c-MET, in Oncogenesis and Potential for Therapeutic Inhibition,”Cytokine&Growth Factor Reviews, 2002, 41-59, vol. 13.

Affiliated with

Also associated with

Rating

Triazolopyrazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazolopyrazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyrazine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4174554